Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
15.44
+0.47 (3.14%)
Nov 22, 2024, 4:00 PM EST - Market closed

Progyny Revenue

Progyny had revenue of $286.63M in the quarter ending September 30, 2024, with 2.04% growth. This brings the company's revenue in the last twelve months to $1.14B, up 10.24% year-over-year. In the year 2023, Progyny had annual revenue of $1.09B with 38.34% growth.

Revenue (ttm)
$1.14B
Revenue Growth
+10.24%
P/S Ratio
1.26
Revenue / Employee
$2,011,890
Employees
566
Market Cap
1.31B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.09B301.69M38.34%
Dec 31, 2022786.91M286.29M57.19%
Dec 31, 2021500.62M155.76M45.17%
Dec 31, 2020344.86M115.18M50.15%
Dec 31, 2019229.68M124.28M117.92%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.26B
Pediatrix Medical Group 2.01B
Novavax 885.19M
STAAR Surgical Company 341.22M
Maravai LifeSciences Holdings 276.92M
Arcus Biosciences 263.00M
Ardelyx 251.85M
Aurinia Pharmaceuticals 220.36M
Revenue Rankings